Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

20.77
+1.477.62%
Volume:142.42K
Turnover:2.88M
Market Cap:2.04B
PE:-3.56
High:20.81
Open:19.98
Low:19.54
Close:19.30
52wk High:42.37
52wk Low:18.29
Shares:98.32M
Float Shares:94.49M
Volume Ratio:0.92
T/O Rate:0.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8316
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-22.03%
PB:-25.53
PE(LYR):-3.56

Loading ...

Ultragenyx Pharma Is Maintained at Overweight by Barclays

Dow Jones
·
Nov 24, 2025

Ultragenyx price target lowered to $50 from $81 at Barclays

TIPRANKS
·
Nov 24, 2025

Ultragenyx Pharmaceutical Inc : Barclays Cuts Target Price to $50 From $81

THOMSON REUTERS
·
Nov 24, 2025

Ultragenyx Pharmaceutical (RARE) Receives a Buy from Barclays

TIPRANKS
·
Nov 24, 2025

Ultragenyx Grants 18,180 Restricted Stock Units to New Hires Under Inducement Plan

Reuters
·
Nov 22, 2025

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Nov 22, 2025

Cantor Fitzgerald Reaffirms Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Nov 21, 2025

J.P. Morgan Sticks to Their Buy Rating for Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Nov 21, 2025

U.S. RESEARCH ROUNDUP-Amgen, Crowdstrike, Micron Technology

Reuters
·
Nov 19, 2025

Ultragenyx Pharmaceutical Inc : JP Morgan Cuts Target Price to $120 From $125

THOMSON REUTERS
·
Nov 19, 2025

Ultragenyx Pharmaceutical (RARE): Exploring Valuation Gaps and Analyst Targets

Simply Wall St.
·
Nov 09, 2025

Stock Track | Ultragenyx Pharmaceutical Plummets 5.10% as Citigroup Cuts Target Price

Stock Track
·
Nov 06, 2025

Ultragenyx Pharmaceutical (RARE) Receives a Buy from Bank of America Securities

TIPRANKS
·
Nov 06, 2025

Ultragenyx Pharmaceutical Inc : Citigroup Cuts Target Price to $103 From $110

THOMSON REUTERS
·
Nov 06, 2025

Ultragenyx Pharma Is Maintained at Buy by Truist Securities

Dow Jones
·
Nov 06, 2025

Positive Outlook for Ultragenyx Pharmaceutical: Buy Rating Affirmed Amid Financial Strength and Product Growth

TIPRANKS
·
Nov 05, 2025

RBC Capital Adjusts Ultragenyx Pharmaceutical Price Target to $72 From $77, Maintains Outperform Rating

MT Newswires Live
·
Nov 05, 2025

Stock Track | Ultragenyx Pharmaceutical Plummets 11.89% Pre-market on Weak Q3 Results and Royalty Sale

Stock Track
·
Nov 05, 2025

Stock Track | Ultragenyx Pharmaceutical Plummets 11.89% Pre-market on Royalty Sale and Weak Q3 Results

Stock Track
·
Nov 05, 2025

Stock Track | Ultragenyx Pharmaceutical Plunges 11.83% Pre-market Following Royalty Sale and Disappointing Q3 Results

Stock Track
·
Nov 05, 2025